Evidence map›Paper›PMID 36093067›Full record

ArticleFrontiers in endocrinology2022

Cross-species comparisons reveal resistance of human skeletal stem cells to inhibition by non-steroidal anti-inflammatory drugs.

L Henry Goodnough, Thomas H Ambrosi, Holly M Steininger, M Gohazrua K Butler, Malachia Y Hoover, HyeRan Choo, Noelle L Van Rysselberghe, Michael J Bellino, Julius A Bishop, Michael J Gardner and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

L Henry GoodnoughDepartment of Orthopaedic Surgery, Stanford Hospitals and Clinics, Stanford, CA, United States.
Thomas H AmbrosiInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Holly M SteiningerInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, United States.
M Gohazrua K ButlerInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Malachia Y HooverInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, United States.
HyeRan ChooDivision of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA, United States.
Noelle L Van RysselbergheDepartment of Orthopaedic Surgery, Stanford Hospitals and Clinics, Stanford, CA, United States.
Michael J BellinoDepartment of Orthopaedic Surgery, Stanford Hospitals and Clinics, Stanford, CA, United States.
Julius A BishopDepartment of Orthopaedic Surgery, Stanford Hospitals and Clinics, Stanford, CA, United States.
Michael J GardnerDepartment of Orthopaedic Surgery, Stanford Hospitals and Clinics, Stanford, CA, United States.
Charles K F ChanInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Stanford University · USStanford Health Care · US

Funding

Mechanisms of Skeletal Stem Cell AgingR00AG049958 · NIA · STANFORD UNIVERSITY · PI CHAN, CHARLES KF · 2018 to 2020
$747k
Reversing Skeletal Aging by Restoring Functional Skeletal Stem Cell DiversityR00AG066963 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI AMBROSI, THOMAS HANS · 2023 to 2025
$742k
BD FACSAria IIS10RR029338 · NCRR · STANFORD UNIVERSITY · PI CLARKE, MICHAEL · 2010 to 2010
$664k
Acquisition of A Microfluidic Chip-Based System for Cluster Sorting and DispensingS10OD028493 · OD · STANFORD UNIVERSITY · PI CHAN, CHARLES KF · 2021 to 2021
$469k
Stanford High Resolution CT Imaging LabS10OD023497 · OD · STANFORD UNIVERSITY · PI DOYLE, TIMOTHY CHARLES · 2017 to 2017
$380k
Reversing Skeletal Aging by Restoring Functional Skeletal Stem Cell DiversityK99AG066963 · NIA · STANFORD UNIVERSITY · PI AMBROSI, THOMAS HANS · 2021 to 2022
$227k
NCRR NIH HHS S10 RR029338NIA NIH HHS K99 AG066963NIA NIH HHS R00 AG049958NIA NIH HHS R00 AG066963NIH HHS S10 OD023497NIH HHS S10 OD028493
6 · The paper itself

Abstract

Fracture healing is highly dependent on an early inflammatory response in which prostaglandin production by cyclo-oxygenases (COX) plays a crucial role. Current patient analgesia regimens favor opioids over Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) since the latter have been implicated in delayed fracture healing. While animal studies broadly support a deleterious role of NSAID treatment to bone-regenerative processes, data for human fracture healing remains contradictory. In this study, we prospectively isolated mouse and human skeletal stem cells (SSCs) from fractures and compared the effect of various NSAIDs on their function. We found that osteochondrogenic differentiation of COX2-expressing mouse SSCs was impaired by NSAID treatment. In contrast, human SSCs (hSSC) downregulated COX2 expression during differentiation and showed impaired osteogenic capacity if COX2 was lentivirally overexpressed. Accordingly, short- and long-term treatment of hSSCs with non-selective and selective COX2 inhibitors did not affect colony forming ability, chondrogenic, and osteogenic differentiation potential

Indexed as

Fractures, BoneOsteogenesisAnimalsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2Cyclooxygenase 2 InhibitorsHumansMiceStem CellsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2Cyclooxygenase 2 Inhibitorsbone regenerationfracture healinginflammationnon-steroid antiinflamatory drugsskeletal stem cells (SSCs)species specificity

Identifiers

PMID36093067
PMCPMC9454294
OpenAlexW4293051587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.